Amphastar Pharmaceuticals (AMPH) Short-term Investments (2013 - 2026)

Amphastar Pharmaceuticals' Short-term Investments history runs 14 years deep, the most recent figure standing at $200000.0 for Q1 2026.

• On a quarterly basis, Short-term Investments changed 0.0% year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was $200000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $235000.0, down 89.32% from the prior year.
• Short-term Investments fell to $200000.0 in Q1 2026 per AMPH's latest filing, from $235000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $16.3 million in Q1 2023 and bottomed at $200000.0 in Q1 2022.
• The 5-year median for Short-term Investments is $235000.0 (2022), against an average of $1.9 million.
• Across the five-year window, Short-term Investments soared 8038.5% in 2023 and sank 98.56% in 2024, its largest moves.
• Year by year, Short-term Investments stood at $235000.0 in 2022, then decreased by 14.89% to $200000.0 in 2023, then surged by 1000.0% to $2.2 million in 2024, then tumbled by 89.32% to $235000.0 in 2025, then decreased by 14.89% to $200000.0 in 2026.
• Per Business Quant, the three latest AMPH Short-term Investments figures stand at $200000.0 (Q1 2026), $235000.0 (Q4 2025), and $200000.0 (Q3 2025).